Berberine Nanosuspension Enhances Hypoglycemic Efficacy on Streptozotocin Induced Diabetic C57BL/6 Mice

Berberine (Ber), an isoquinoline derivative alkaloid and active ingredient of Coptis, has been demonstrated to possess antidiabetic activities. However its low oral bioavailability restricts its clinical application. In this report, Ber nanosuspension (Ber-NS) composed of Ber and D-α-tocopheryl poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiping, Wu, Junbiao, Zhou, Qun, Wang, Yifei, Chen, Tongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381853/
https://www.ncbi.nlm.nih.gov/pubmed/25866534
http://dx.doi.org/10.1155/2015/239749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381853/
https://www.ncbi.nlm.nih.gov/pubmed/25866534
http://dx.doi.org/10.1155/2015/239749

Ejemplares similares